Pembrolizumab-Induced Delayed-Onset Hepatitis

Pembrolizumab-Induced Delayed-Onset Hepatitis

Hepatitis is one of the serious immune-related adverse events (irAEs). However, delayed-onset hepatitis induced by immune-checkpoint inhibitors (ICIs) is rare, and the histopathological features remain to be clarified. A 65-year-old woman with advanced lung adenocarcinoma in the right upper lobe (cT...

Full description

Bibliographic Details
Main Authors: Kensuke Kanaoka, Kazunori Moriizumi, Hideyasu Okada, Kiyoshi Iwahashi, Hiromi Tsuji, Hironao Yasuoka, Seigo Minami
Format: Article
Language:English
Published: Karger Publishers 2020-11-01
Series:Case Reports in Gastroenterology
Subjects:
pembrolizumab
immune-related adverse events
hepatitis
cd3-positive lymphocyte
cd8-positive lymphocyte
Online Access:https://www.karger.com/Article/FullText/509953

Similar Items

Similar Items